本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

6.92
-1.1600-14.36%
盤後6.86-0.0597-0.86%16:54 EDT
成交量:374.78萬
成交額:2,529.77萬
市值:1.34億
市盈率:-1.14
高:8.08
開:8.08
低:6.33
收:8.08
52周最高:20.56
52周最低:6.33
股本:1,934.13萬
流通股本:1,741.65萬
量比:1.41
換手率:21.52%
股息:- -
股息率:- -
每股收益(TTM):-6.0889
每股收益(LYR):-5.9000
淨資產收益率:-95.58%
總資產收益率:-53.00%
市淨率:1.31
市盈率(LYR):-1.17

資料載入中...

2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/20

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/18

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report